Latest Articles

Publication Date
Stoke-on-Trent City Council becomes endometriosis-friendly employer - Employee Benefits

Stoke-on-Trent City Council becomes endometriosis-friendly employer Employee Benefits

Published: March 21, 2025, 12:21 p.m.
Bowel Endometriosis: Systematic Approach to Diagnosis with US and MRI.

Endometriosis involving the bowel is a severe form of the disease, and the bowel is the most common site of extragenital endometriosis. Surface lesions of the bowel are considered peritoneal …

Published: March 21, 2025, midnight
Real-World Data Support Dostarlimab Combo Benefit in RUBY Trial - Cancer Network

Real-World Data Support Dostarlimab Combo Benefit in RUBY Trial Cancer Network

Published: March 20, 2025, 8:01 p.m.
Chronic Pelvic Pain in Women: Evaluation and Treatment.

Chronic pelvic pain affects up to 26% of individuals with female anatomy and is defined as at least 6 months of pain that is perceived to originate in the pelvis. …

Published: March 20, 2025, midnight
Utilising Human Myometrial and Uterine Fibroid Stem Cell-Derived Three Dimentional Organoids as a Robust Model System for Understanding the Pathophysiology of Uterine Fibroids.

Uterine fibroids (UFs) are the most common benign gynecologic tumours affecting women of reproductive age. This study aims to deepen the understanding of UFs complex aetiology through harnessing the power …

Published: March 20, 2025, midnight
Development of the COMPASS model of endometriosis: A COmprehensive model of pain encompassing agency, systemic factors and sense making.

Endometriosis is a chronic and progressive condition commonly associated with debilitating pain. Treatments for endometriosis pain are limited and usually invasive. Psychological interventions are a non-invasive intervention option and have …

Published: March 19, 2025, 12:13 a.m.
Work and Pensions Secretary sets out overhaul of benefits system - Shropshire Star

Work and Pensions Secretary sets out overhaul of benefits system Shropshire Star

Published: March 18, 2025, 1:40 p.m.
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups - OBR Oncology

Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups OBR Oncology

Published: March 18, 2025, 10:24 a.m.
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups - Oncology News Central

Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups Oncology News Central

Published: March 18, 2025, 10:24 a.m.
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups - oncologynewscentral.com

Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups oncologynewscentral.com

Published: March 18, 2025, 10:24 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!